These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8463729)

  • 1. Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits.
    Saettone MF; Chetoni P; Cappanera L; Conte U; Finne U; Järvinen K; Salivirta J; Urtti A
    J Ocul Pharmacol; 1993; 9(1):1-12. PubMed ID: 8463729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
    Urtti A; Rouhiainen H; Kaila T; Saano V
    Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular mini-tablets for controlled release of timolol: evaluation in rabbits.
    Chetoni P; Mariotti Bianchi L; Giannaccini B; Saettone MF; Conte U; Sangalli ME
    J Ocul Pharmacol Ther; 1996; 12(3):245-52. PubMed ID: 8875330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic differences between ocular inserts and eyedrops.
    Friedrich SW; Saville BA; Cheng YL; Rootman DS
    J Ocul Pharmacol Ther; 1996; 12(1):5-18. PubMed ID: 8925396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
    Kyyrönen K; Urtti A
    J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of different eyedrop preparations of timolol in rabbits.
    Järvinen K; Urtti A
    Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of drug release rate on systemic timolol absorption from polymeric ocular inserts in the pigmented rabbit.
    Lee VH; Li SY; Sasaki H; Saettone MF; Chetoni P
    J Ocul Pharmacol; 1994; 10(2):421-9. PubMed ID: 8083561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular release of timolol from molecularly imprinted soft contact lenses.
    Hiratani H; Fujiwara A; Tamiya Y; Mizutani Y; Alvarez-Lorenzo C
    Biomaterials; 2005 Apr; 26(11):1293-8. PubMed ID: 15475059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM; Kaila T; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of timolol containing calcium-phosphate nanoparticles and evaluation of their effect on intraocular pressure in experiment].
    Shimanovskaia EV; Beznos OV; Kliachko NL; Kost OA; Nikol'skaia II; Pavlenko TA; Chesnokova NB; Kabanov AV
    Vestn Oftalmol; 2012; 128(3):15-8. PubMed ID: 23120918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xyloglucan as a novel vehicle for timolol: pharmacokinetics and pressure lowering activity in rabbits.
    Burgalassi S; Chetoni P; Panichi L; Boldrini E; Saettone MF
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):497-509. PubMed ID: 11132897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced ocular hypotensive response to timolol in rabbits with prior dexamethasone treatment.
    Schwartz B; Rom ME
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):27-33. PubMed ID: 11322635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
    Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
    Aggarwal D; Kaur IP
    Int J Pharm; 2005 Feb; 290(1-2):155-9. PubMed ID: 15664141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
    Hegde RR; Bhattacharya SS; Verma A; Ghosh A
    Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-side-coated insert as a unique ophthalmic drug delivery system.
    Sasaki H; Nagano T; Sakanaka K; Kawakami S; Nishida K; Nakamura J; Ichikawa N; Iwashita J; Nakamura T; Nakashima M
    J Control Release; 2003 Oct; 92(3):241-7. PubMed ID: 14568405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosslinked soy protein films and their application as ophthalmic drug delivery system.
    González A; Tártara LI; Palma SD; Alvarez Igarzabal CI
    Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():73-9. PubMed ID: 25842110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.